SOURCE-LINKED INTELLIGENCE

INDIVIDUALIZED IMMUNOSUPPRESSION IN ORGAN TRANSPLANT RECIPIENTS BASED ON REAL WORLD EVIDENCE AND ARTIFICIAL INTELLIGENCE - PROJECT SUMMARY OVER 250,000 KIDNEY TRANSPLANT (KT) RECIPIENTS DEPEND ON LIFELONG IMMUNOSUPPRESSI

USAspending · observation · Publication date unknown

INDIVIDUALIZED IMMUNOSUPPRESSION IN ORGAN TRANSPLANT RECIPIENTS BASED ON REAL WORLD EVIDENCE AND ARTIFICIAL INTELLIGENCE - PROJECT SUMMARY OVER 250,000 KIDNEY TRANSPLANT (KT) RECIPIENTS DEPEND ON LIFELONG IMMUNOSUPPRESSIVE THERAPY TO PREVENT REJECTION AND GRAFT FAILURE. HOWEVER, IMMUNOSUPPRESSION INCREASES THE RISK OF COMPLICATIONS SUCH AS INFECTIONS, CANCER, AND CARDIOVASCULAR DISEASE (CVD), WHICH TOGETHER ACCOUNT FOR >70% OF DEATHS IN KT PATIENTS. TO OPTIMIZE TRANSPLANT OUTCOMES WHILE MINIMIZING IMMUNOSUPPRESSION-ASSOCIATED ADVERSE DRUG EVENTS (ADES), CLINICIANS AIM TO CHOOSE THE MOST APPROP

Read original source ↗ Open in workspace

recordType

award

region

US

value

1693725

unit

USD